146 related articles for article (PubMed ID: 8412192)
1. TGF-alpha and EGFR in head and neck cancer.
Grandis JR; Tweardy DJ
J Cell Biochem Suppl; 1993; 17F():188-91. PubMed ID: 8412192
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
Grandis JR; Tweardy DJ
Cancer Res; 1993 Aug; 53(15):3579-84. PubMed ID: 8339264
[TBL] [Abstract][Full Text] [Related]
3. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.
Seethala RR; Gooding WE; Handler PN; Collins B; Zhang Q; Siegfried JM; Grandis JR
Clin Cancer Res; 2008 Mar; 14(5):1303-9. PubMed ID: 18316548
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines.
Rubin Grandis J; Zeng Q; Tweardy DJ
Nat Med; 1996 Feb; 2(2):237-40. PubMed ID: 8574972
[TBL] [Abstract][Full Text] [Related]
6. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Grandis JR; Chakraborty A; Zeng Q; Melhem MF; Tweardy DJ
J Cell Biochem; 1998 Apr; 69(1):55-62. PubMed ID: 9513046
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
[TBL] [Abstract][Full Text] [Related]
8. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
Rubin Grandis J; Tweardy DJ; Melhem MF
Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
[TBL] [Abstract][Full Text] [Related]
9. Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region.
Wu M; Putti TC; Bhuiya TA
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):351-6. PubMed ID: 12607604
[TBL] [Abstract][Full Text] [Related]
10. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
11. STAT signaling in head and neck cancer.
Song JI; Grandis JR
Oncogene; 2000 May; 19(21):2489-95. PubMed ID: 10851047
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor alpha stimulation of mucosal tissue cultures from head and neck squamous cell carcinoma patients increases chemoresistance to cisplatin.
Baumeister P; Reiter M; Schwenk-Zieger S; Harréus U
Chemotherapy; 2010; 56(4):268-74. PubMed ID: 20693797
[TBL] [Abstract][Full Text] [Related]
13. Transforming Growth Factor-alpha reduces carcinogen-induced DNA damage in mini-organ cultures from head-and-neck cancer patients.
Baumeister P; Schwenk-Zieger S; Reiter M; Welz C; Harréus U
Mutat Res; 2009; 677(1-2):42-5. PubMed ID: 19539778
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
Song JI; Lango MN; Hwang JD; Drenning SD; Zeng Q; Lamph WW; Grandis JR
Cancer Res; 2001 Aug; 61(15):5919-25. PubMed ID: 11479234
[TBL] [Abstract][Full Text] [Related]
15. Targeting the epidermal growth factor receptor for head and neck cancer chemoprevention.
Mak MP; William WN
Oral Oncol; 2014 Oct; 50(10):918-23. PubMed ID: 24412287
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-alpha: a surrogate endpoint biomarker?
Beenken SW; Hockett R; Grizzle W; Weiss HL; Pickens A; Perloff M; Malone WF; Bland KI
J Am Coll Surg; 2002 Aug; 195(2):149-58. PubMed ID: 12168960
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of the epidermal growth factor receptor and transforming growth factor-alpha during multistage skin carcinogenesis in SENCAR mice.
Rho O; Beltrán LM; Gimenez-Conti IB; DiGiovanni J
Mol Carcinog; 1994 Sep; 11(1):19-28. PubMed ID: 7916986
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of epidermal growth factor receptor and TGF-alpha and survival in upper aerodigestive tract cancer.
Issing WJ; Liebich C; Wustrow TP; Ullrich A
Anticancer Res; 1996; 16(1):283-8. PubMed ID: 8615622
[TBL] [Abstract][Full Text] [Related]
19. Patterns of expressions of transforming growth factor and epidermal growth factor receptor in squamous cell lesions of the urinary bladder.
Tungekar MF; Linehan J
J Clin Pathol; 1998 Aug; 51(8):583-7. PubMed ID: 9828815
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation.
Iihara K; Shiozaki H; Tahara H; Kobayashi K; Inoue M; Tamura S; Miyata M; Oka H; Doki Y; Mori T
Cancer; 1993 May; 71(10):2902-9. PubMed ID: 8490817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
